Tra2β, SF2/ASF and SRp30c modulate the function of an exonic splicing enhancer in exon 10 of tau pre-mRNA

Genes to Cells

Volumn 9, Issue 2, 2004, Pages 121-130

  Kondo, Shinichi ^a   Yamamoto, Noriaki ^a   Murakami, Tomohiko ^a   Okumura, Masayo ^a   Mayeda, Akila ^b   Imaizumi, Kazunori ^a  

^a NARA INSTITUTE OF SCIENCE AND TECHNOLOGY   (Japan)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; MESSENGER RNA; PROTEIN SF2; PROTEIN SRP30C; PROTEIN TRA2BETA; RNA PRECURSOR; TAU PROTEIN; UNCLASSIFIED DRUG;

5' UNTRANSLATED REGION; ALTERNATIVE RNA SPLICING; ANIMAL CELL; ARTICLE; BINDING ASSAY; CHROMOSOME 17; COMORBIDITY; CONTROLLED STUDY; ENHANCER REGION; EXON; FRONTOTEMPORAL DEMENTIA; HUMAN; HUMAN CELL; IN VITRO STUDY; MICROTUBULE; MOLECULAR DYNAMICS; MUTATIONAL ANALYSIS; NEUROBLASTOMA; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL; PROTEIN MOTIF; PROTEIN RNA BINDING; TUMOR CELL LINE;

ALTERNATIVE SPLICING; ANIMALS; CELL LINE; ENHANCER ELEMENTS (GENETICS); EXONS; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; MUTATION, MISSENSE; NERVE TISSUE PROTEINS; NEUROPEPTIDES; NUCLEAR PROTEINS; PHOSPHOPROTEINS; PROTEIN BINDING; RNA PRECURSORS; RNA, MESSENGER; RNA-BINDING PROTEINS; SEQUENCE DELETION; TAU PROTEINS;

EID: 1542330117     PISSN: 13569597     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1356-9597.2004.00709.x     Document Type: Article

References (48)

1. Bird, T.D., Wijsman, E.M., Nochlin, D., et al. (1997) Chromosome 17 and hereditary dementia: linkage studies in three non-Alzheimer families and kindreds with late-onset FAD. Neurology 48, 949-954.
2. Blencowe, B.J. (2000) Exonic splicing enhancers: mechanism of action, diversity and role in human genetic diseases. Trends Biochem. Sci. 25, 106-110.
3. Cartegni, L., Chew, S.L. & Krainer, A.R. (2002) Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nature Rev. Genet. 3, 285-298.
4. Cartegni, L. & Krainer, A.R. (2002) Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1. Nature Genet. 30, 377-384.
5. Church, D.M., Stotler, C.J., Rutter, J.L., Murrell, J.R., Trofatter, J.A. & Buckler, A.J. (1994) Isolation of genes from complex sources of mammalian genomic DNA using exon amplification. Nature Genet. 6, 98-105.
6. Clark, L.N., Poorkaj, P. & Wszolek, Z. (1998) Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17. Proc. Natl. Acad. Sci. USA 95, 13103-13107.
7. D'Souza, I., Poorkaj, P., Hong, M., et al. (1999) Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements. Proc. Natl. Acad. Sci. USA 96, 5598-5603.
8. De Jonghe, C., Cruts, M., Rogaeva, E.A., et al. (1999) Aberrant splicing in the presenilin-1 intron 4 mutation causes presenile Alzheimer's disease by increased Aβ42 secretion. Hum. Mol. Genet. 8, 1529-1540.
9. Estmer Nilsson, C., Petersen-Mahrt, S., Durot, C., et al. (2001) The adenovirus E4-ORF4 splicing enhancer protein interacts with a subset of phosphorylated SR proteins. EMBO J. 20, 864-871.
10. Foster, N.L., Wilhelmsen, K., Sima, A.A., Jones, M.Z., D'Amato, C.J. & Gilman, S. (1997) Frontotemporal dementia and parkinsonism linked to chromosome 17: a consensus conference. Conference Participants. Ann, Neurol. 41, 706-715.
11. Goedert, M., Spillantini, M.G. & Davies, S.W. (1998) Filamentous nerve cell inclusions in neurodegenerative diseases. Curr. Opin. Neurobiol. 8, 619-632.
12. Goode, B.L., Chau, M., Denis, P.E. & Feinstein, S.C. (2000) Structural and functional differences between 3-repeat and 4-repeat tau isoforms. Implications for normal tau function and the onset of neurodegenetative disease. J. Biol. Chem. 275, 38182-38189.
13. Graveley, B.R. (2000) Sorting out the complexity of SR protein functions. RNA 6, 1197-1211.
14. Graveley, B.R., Hertel, K.J. & Maniatis, T. (1998) A systematic analysis of the factors that determine the strength of pre-mRNA splicing enhancers. EMBO J. 17, 6747-6756.
15. Grover, A., Houlden, H., Baker, M., et al. (1999) 5′ splice site mutations in tau associated with the inherited dementia FTDP-17 affect a stem-loop structure that regulates alternative splicing of exon 10. J. Biol. Chem. 274, 15134-15143.
16. Hasegawa, M., Smith, M.J. & Goedert, M. (1998) Tau proteins with FTDP-17 mutations have a reduced ability to promote microtubule assembly. FEBS Lett. 437, 207-210.
17. Hasegawa, M., Smith, M.J., Iijima, M., Tabira, T. & Goedert, M. (1999) FTDP-17 mutations N279K and S305N in tau produce increased splicing of exon 10. FEBS Lett. 443, 93-96.
18. Heutink, P., Stevens, M., Rizzu, P., et al. (1997) Hereditary frontotemporal dementia is linked to chromosome 17q21-q22: a genetic and clinicopathological study of three Dutch families. Ann. Neurol. 41, 150-159.
19. Hong, M., Zhukareva, V., Vogelsberg-Ragaglia, V., et al. (1998) Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. Science 282, 1914-1917.
20. Hutton, M., Lendon, C.L., Rizzu, P., et al. (1998) Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393, 702-705.
21. Iseki, E., Matsumura, T., Marui, W., et al. (2001) Familial frontotemporal dementia and parkinsonism with a novel N296H mutation in exon 10 of the tau gene and a widespread tau accumulation in the glial cells. Acta Neuropathol. 102, 285-292.
22. Jiang, Z., Cote, J., Kwon, J.M., Goate, A.M. & Wu, J.Y. (2000) Aberrant splicing of tau pre-mRNA caused by intronic mutations associated with the inherited dementia frontotemporal dementia with parkinsonism linked to chromosome 17. Mol. Cell. Biol. 20, 4036-4048.
23. Jiang, Z., Tang, H., Havlioglu, N., et al. (2003) Mutations in tau gene exon 10 associated with FTDP-17 alter the activity of an exonic splicing enhancer to interact with Tra2 β. J. Biol. Chem. 278, 18997-19007.
24. Lin, C.L., Bristol, L.A., Jin, L., et al. (1998) Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis. Neuron 20, 589-602.
25. Liu, H.X., Cartegni, L., Zhang, M.Q. & Krainer, A.R. (2001) A mechanism for exon skipping caused by nonsense or missense mutations in BRCA1 and other genes. Nature Genet. 27, 55-58.
26. Lynch, T., Sano, M., Marder, K.S., et al. (1994) Clinical characteristics of a family with chromosome 17-linked disinhibition-dementia-parkinsonism-amyotrophy complex. Neurology 44, 1878-1884.
27. Maniatis, T. (1991) Mechanisms of alternative pre-mRNA splicing. Science 251, 33-34.
28. Mayeda, A. & Krainer, A.R. (1999) Preparation of HeLa cell nuclear and cytosolic S100 extracts for in vitro splicing. Methods Mol. Biol. 118, 309-314.
29. Miyajima, H., Miyaso, H., Okumura, M., Kurisu, J. & Imaizumi, K. (2002) Identification of a cis-acting element for the regulation of SMN exon 7 splicing. J. Biol. Chem. 277, 23271-23277.
30. Perez-Tur, J., Froelich, S., Prihar, G., et al. (1995) A mutation in Alzheimer's disease destroying a splice acceptor site in the presenilin-1 gene. Neuroreport 7, 297-301.
31. Reed, L.A., Grabowski, T.J., Schmidt, M.L., et al. (1997) Autosomal dominant dementia with widespread neurofibrillary tangles. Ann. Neurol. 42, 564-572.
32. Screaton, G.R., Caceres, J.F., Mayeda, A., et al. (1995) Identification and characterization of three members of the human SR family of pre-mRNA. EMBO J. 14, 4336-4349.
33. Smith, C.W., Patton, J.G. & Nadal-Ginard, B. (1989) Alternative splicing in the control of gene expression. Annu. Rev. Genet. 23, 973-977.
34. Spillantini, M.G., Crowther, R.A. & Goedert, M. (1996) Comparison of the neurofibrillary pathology in Alzheimer's disease and familial presenile dementia with tangles. Acta Neuropathol (Berl). 92, 42-48.
35. Spillantini, M.G., Goedert, M., Crowther, R.A., Murrell, J.R., Farlow, M.R. & Ghetti, B. (1997) Familial multiple system tauopathy with presenile dementia: a disease with abundant neuronal and glial tau filaments. Proc. Natl. Acad. Sci. USA 94, 4113-4118.
36. Spillantini, M.G., Murrell, J.R., Goedert, M., Farlow, M.R., Klug, A. & Ghetti, B. (1998) Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc. Natl. Acad. Sci. USA 95, 7737-7741.
37. Spillantini, M.G., Yoshida, H., Rizzini, C., et al. (2000) A novel tau mutation (N296N) in familial dementia with swollen achromatic neurons and corticobasal inclusion bodies. Ann. Neurol. 48, 939-943.
38. Stoss, O., Schwaiger, F.W., Cooper, T.A. & Stamm, S. (1999) Alternative splicing determines the intracellular localization of the novel nuclear protein Nop30 and its interaction with the splicing factor SRp30c. J. Biol. Chem. 274, 10951-10962.
39. Tacke, R., Tohyama, M., Ogawa, S. & Manley, J.L. (1998) Human Tra2 proteins are sequence-specific activators of pre-mRNA splicing. Cell 93, 139-148.
40. Tanaka, K., Watakabe, A. & Shimura, Y. (1994) Polypurine sequences within a downstream exon function as a splicing enhancer. Mol. Cell. Biol. 14, 1347-1354.
41. Tian, M. & Maniatis, T. (1992) Positive control of pre-mRNA splicing in vitro. Science 256, 237-240.
42. Tian, M. & Maniatis, T. (1994) A splicing enhancer exhibits both constitutive and regulated activities. Genes Dev. 8, 1703-1712.
43. Tysoe, C., Whittaker, J., Xuereb, J., et al. (1998) A presenilin-1 truncating mutation is present in two cases with autopsy-confirmed early-onset Alzheimer disease. Am. J. Hum. Genet. 62, 70-76.
44. Varani, L., Spillantini, M.G., Goedert, M. & Varani, G. (2000) Structural basis for recognition of the RNA major groove in the tau exon 10 splicing regulatory element by aminoglycoside antibiotics. Nucl. Acids Res. 28, 710-719.
45. Wijker, M., Wszolek, Z.K., Wolters, E.C., et al. (1996) Localization of the gene for rapidly progressive autosomal dominant parkinsonism and dementia with pallido-ponto-nigral degeneration to chromosome 17q21. Hum. Mol. Genet. 5, 151-154.
46. Wilhelmsen, K.C., Lynch, T., Pavlou, E., Higgins, M. & Nygaard, T.G. (1994) Localization of disinhibition-dementia-parkinsonism-amyotrophy complex to 17q21-22. Am. J. Hum. Genet. 55, 1159-1165.
47. Yamaoka, L.H., Welsh-Bohmer, K.A., Hulette, C.M., et al. (1996) Linkage of frontotemporal dementia to chromosome 17: clinical and neuropathological characterization of phenotype. Am. J. Hum. Genet. 59, 1306-1312.
48. Young, P.J., DiDonato, C.J., Hu, D., Kothary, R., Androphy, E.J. & Lorson, C.L. (2002) SRp30c-dependent stimulation of survival motor neuron (SMN) exon 7 inclusion is facilitated by a direct interaction with hTr+a2 β 1. Hum. Mol. Genet. 11, 577-587.